IO Biotech ApS

IO Biotech ApS is a clinical stage  company developing disruptive immune therapies i.e. checkpoint/cancer vaccines. Checkpoint/cancer vaccines suppress the function of regulatory immune cells and induce inflammation in the micro-environment in addition to direct targeting of cancer cells. 

Contact name:

Mai-Britt Zocca


Ole Maaløes Vej 3, 2200 Copenhagen, Denmark

If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact or +45 5150 0560

Copyright 2016 Danskbiotek. All rights reserved.